ArticleJournal of the American Heart Association2017
Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.
Article in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Long-term mortality and causes of death after venous thromboembolism: findings from the Atherosclerosis Risk in Communities Cohort Study.Journal of thrombosis and haemostasis : JTH · 2026Article
- Prevalence of cardiovascular risk factors in persons with venous thromboembolism aged 50 years or younger.Blood vessels, thrombosis & hemostasis · 2025Article
- Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study.Thrombosis journal · 2024Article
- Editorial: Highlights in Thrombosis: 2021.Frontiers in cardiovascular medicine · 2022Article
- Development of Risk Prediction Model for Muscular Calf Vein Thrombosis with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.International journal of general medicine · 2022Article
- Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis.TH open : companion journal to thrombosis and haemostasis · 2021Article
- Article
- Is Hematopoietic Clonality of Indetermined Potential a Risk Factor for Pulmonary Embolism?TH open : companion journal to thrombosis and haemostasis · 2021Article
- The effect of deep vein thrombosis on major adverse limb events in diabetic patients: a nationwide retrospective cohort study.Scientific reports · 2021Article
- Long-Term Survival After Venous Thromboembolism: A Prospective Cohort Study.Frontiers in cardiovascular medicine · 2021Article
- Is there a link between venous and arterial thrombosis? A reappraisal.Internal and emergency medicine · 2020Review
- Incidence and risk of venous thromboembolism in patients following appendectomy: a nationwide cohort study.Journal of thrombosis and thrombolysis · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with unprovoked venous thromboembolism (VTE) are at an increased risk of mortality, but whether their cardiovascular risks also increase remains to be determined. We aimed to investigate the factors associated with overall mortality and major adverse cardiovascular events in patients with unprovoked VTE. METHODS AND
resultsWe identified 2154 patients newly diagnosed with unprovoked VTE from Taiwan's National Health Insurance Database between 2000 and 2013, excluding those with reversible etiologies, underlying cancer, or autoimmune diseases. These patients with VTE were compared with an age-, sex-, and cardiovascular risk-matched cohort of 4308 controls. The risk of mortality and major adverse cardiovascular events in patients with VTE was 2.23 (CI, 1.93-2.57;
conclusionsThis nation-wide cohort study revealed that patients with unprovoked VTE, particularly older males with diabetes mellitus, had an elevated risk of both mortality and cardiovascular events. Risk of mortality and major adverse cardiovascular events were highest within the first year after diagnosis and persisted during the 10 years of follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.